Cost-consequence analysis of ofatumumab for the treatment of relapsing-remitting multiple sclerosis in Canada

• Hoofdauteurs: Virender Bhan (Auteur), Fraser Clift (Auteur), Moogeh Baharnoori (Auteur), Kimberly Thomas (Auteur), Barkha P Patel (Auteur), Francois Blanchette (Auteur), Nicholas Adlard (Auteur), Umakanth Vudumula (Auteur), Kapil Gudala (Auteur), Nikkita Dutta (Auteur), Daniel Grima (Auteur), Soukaina Mouallif (Auteur), Fatine Farhane (Auteur)
• Formaat: Boek
• Gepubliceerd in: Becaris Publishing Limited, 2023-08-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Aim: The costs and consequences of initial and delayed ofatumumab treatment were evaluated in relapsing-remitting multiple sclerosis with active disease in Canada. Materials & methods: A Markov cohort model was used (10-year horizon, annual cycle length, 1.5% discounting). Scenario analyses exam...